Novo Nordisk starts trialing lower maintenance doses of oral Wegovy
BioSpace
The Phase 3 study is evaluating two doses of Novo's Wegovy pill in people with obesity or overweight in combination with a reduced-calorie diet and increased physical activity.
pharminent
August 21, 2026 (Last updated: August 23, 2026)
BioSpace
The Phase 3 study is evaluating two doses of Novo’s Wegovy pill in people with obesity or overweight in combination with a reduced-calorie diet and increased physical activity.
